sulbactam has been researched along with Kawasaki Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akat, H; Laloglu, F; Orbak, Z | 1 |
| Han, SB; Lee, SY | 1 |
2 other study(ies) available for sulbactam and Kawasaki Disease
| Article | Year |
|---|---|
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
Topics: Ampicillin; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Drug Combinations; Enoxaparin; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lung; Male; Mucocutaneous Lymph Node Syndrome; Oseltamivir; Oxygen Inhalation Therapy; Ritonavir; Sulbactam; Tomography, X-Ray Computed | 2021 |
Antibiotic use in children with Kawasaki disease.
Topics: Age Factors; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; C-Reactive Protein; Cefotaxime; Child, Preschool; Diagnosis, Differential; Diagnostic Errors; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Leukocytosis; Male; Mucocutaneous Lymph Node Syndrome; Pyuria; Republic of Korea; Retrospective Studies; Sulbactam | 2018 |